Latest Headlines

  1. Abionic Signs Agreement To Optimize Asthma Management In The U.S. Through Innovative Rapid Point-Of-Care Tests

    Abionic SA, the developer of proprietary disruptive nanotechnology based rapid diagnostic solutions, and Genentech, a member of the Roche Group, announced recently a strategic agreement to develop and provide an In Vitro Diagnostic (IVD) Asthma Test Panel using Abionic’s POC abioSCOPE platform in the United States.

  2. ChunLab Releases Beta Version Of TrueBac ID, The Genome-Based Diagnostic Solution For Bacterial Identification

    ChunLab, a leader in the field of bioinformatics for bacterial taxonomy and microbiome, released the beta version of TrueBacTM ID system, the world's first genome-based cloud solution for bacterial identification, targeting over 12,000 species

  3. American Society For Gastrointestinal Endoscopy Includes WATS3D In Its New Practice Guideline For The Screening And Surveillance Of Barrett’s Esophagus

    CDx Diagnostics, developer of the WATS3D diagnostic platform for the screening and surveillance of Barrett’s esophagus (BE), a known precursor to esophageal cancer (EC), today announced that the American Society for Gastrointestinal Endoscopy (ASGE) has included WATS3D in its Standards of Practice Committee’s guideline for the screening and surveillance of BE. A copy of the Standards of Practice Committee’s guideline can be found here

  4. Instrumentation Laboratory Awarded Point-Of-Care Coagulation/Patient Blood Management Agreement With Premier

    Instrumentation Laboratory (IL), today, announced their award of a group-purchasing agreement for Point-of-Care (POC) Coagulation/Patient Blood Management (PBM) from Premier

  5. UniPath Announces New Clinical Lab Service In Colorado

    UniPath, a specialized anatomic and molecular pathology laboratory, announced today it now offers comprehensive clinical lab services to Colorado physicians and their patients

  6. Todos Medical Enters Into MOU To Expand Existing Early Detection Breast Cancer Blood Test Distribution Partnership With Orot+ Into Japan

    Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that the Company has entered into a non-binding Memorandum of Understanding (MOU) with Orot+, the operational division of Orot-Luces (, to expand their existing launch and distribution partnership for the commercial sale of Todos’ early breast cancer detection blood tests TM-B1 and TM-B2 into Japan

  7. Fred Hutchinson Cancer Research Center And Leica Microsystems Establish Center Of Excellence In Microscopy

    Fred Hutchinson Cancer Research Center (Fred Hutch) and Leica Microsystems, Inc. have combined efforts to establish the Leica Microsystems Center of Excellence at Fred Hutch

  8. Thermo Fisher Scientific Announces Collaboration To Develop Advanced Analytical Workflows For Clinical Laboratories

    Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications

  9. Laboratory For Advanced Medicine Receives FDA Breakthrough Device Designation For Liquid Biopsy Liver Cancer Detection Test

    Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company with innovative technologies for the early diagnosis of cancer, today announced that its Liver Cancer detection test has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA)

  10. Quick & Efficient Sample Homogenisation For Plasmid Protocols

    Porvair Sciences announce the new Chromatrap Homogeniser Spin Column which provides a quick, cost effective way to homogenize cells and tissues lysates in a single step